Cholesterol as a co-solvent and a ligand for membrane proteins

Protein Science

Volumn 23, Issue 1, 2014, Pages 1-22

  Song, Yuanli ^a   Kenworthy, Anne K ^a   Sanders, Charles R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; C99; Cholesterol; CRAC; GPCRs; Integral membrane proteins; Receptor; CTF

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLESTEROL; GLYCEROPHOSPHOLIPID;

ALZHEIMER DISEASE; BINDING SITE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL METABOLISM; CRYSTAL STRUCTURE; HEART DISEASE; HOMEOSTASIS; HUMAN; MEMBRANE FLUIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW;

ALZHEIMER'S DISEASE; AMYLOID PRECURSOR PROTEIN; C99; CHOLESTEROL; CRAC; GPCRS; INTEGRAL MEMBRANE PROTEINS; RECEPTOR; Β-CTF;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BINDING SITES; CHOLESTEROL; HUMANS; LIGANDS; MEMBRANE PROTEINS; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

EID: 84895768344     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2385     Document Type: Review

References (162)

1. Evans WH, Hardison WG (1985) Phospholipid, cholesterol, polypeptide and glycoprotein composition of hepatic endosome subfractions. Biochem J 232:33-36
2. Zambrano F, Fleischer S, Fleischer B (1975) Lipid composition of the Golgi apparatus of rat kidney and liver in comparison with other subcellular organelles. Biochim Biophys Acta 380:357-369
3. Mitra K, Ubarretxena-Belandia I, Taguchi T, Warren G, Engelman DM (2004) Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol. Proc Natl Acad Sci USA 101:4083-4088
4. Andreyev AY, Fahy E, Guan Z, Kelly S, Li X, McDonald JG, Milne S, Myers D, Park H, Ryan A, Thompson BM, Wang E, Zhao Y, Brown HA, Merrill AH, Raetz CR, Russell DW, Subramaniam S, Dennis EA (2010) Subcellular organelle lipidomics in TLR-4- activated macrophages. J Lipid Res 51:2785-2797
5. Wood WG, Cornwell M, Williamson LS (1989) High performance thin-layer chromatography and densitometry of synaptic plasma membrane lipids. J Lipid Res 30:775-779
6. Daum G (1985) Lipids of mitochondria. Biochim Biophys Acta 822:1-42
7. van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: Where they are and how they behave. Nat Rev Mol Cell Biol 9:112-124
8. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: A delicate balance. Cell Metab 8:512-521
9. Ourisson G, Albrecht P (1992) Hopanoids. 1. Geohopanoids: The most abundant natural products on Earth? Acc Chem Res 25:398-402
10. Ourisson G, Rohmer M (1992) Hopanoids. 2. Biohopanoids: A novel class of bacterial lipids. Acc Chem Res 25:403-408
11. Saenz JP, Sezgin E, Schwille P, Simons K (2012) Functional convergence of hopanoids and sterols in membrane ordering. Proc Natl Acad Sci USA 109:14236-14240
12. Beattie ME, Veatch SL, Stottrup BL, Keller SL (2005) Sterol structure determines miscibility versus melting transitions in lipid vesicles. Biophys J 89:1760-1768
13. Wenz JJ (2012) Predicting the effect of steroids on membrane biophysical properties based on the molecular structure. Biochim Biophys Acta 1818:896-906
14. Xu X, London E (2000) The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39:843-849
15. Mouritsen OG, Zuckermann MJ (2004) What?s so special about cholesterol? Lipids 39:1101-1113
16. Galea AM, Brown AJ (2009) Special relationship between sterols and oxygen: Were sterols an adaptation to aerobic life? Free Radic Biol Med 47:880-889
17. Chen LL, Wang GZ, Zhang HY (2007) Sterol biosynthesis and prokaryotes-to-eukaryotes evolution. Biochem Biophys Res Commun 363:885-888
18. Summons RE, Bradley AS, Jahnke LL, Waldbauer JR( 2006) Steroids, triterpenoids and molecular oxygen. Philos Trans R Soc London B Biol Sci 361:951-968
19. Mannock DA, Lewis RN, McMullen TP, McElhaney RN( 2010) The effect of variations in phospholipid and sterol structure on the nature of lipid-sterol interactions in lipid bilayer model membranes. Chem Phys Lipids 163:403-448
20. Harroun TA, Katsaras J, Wassall SR (2008) Cholesterol is found to reside in the center of a polyunsaturated lipid membrane. Biochemistry 47:7090-7096
21. Kucerka N, Marquardt D, Harroun TA, Nieh MP, Wassall SR, Katsaras J (2009) The functional significance of lipid diversity: Orientation of cholesterol in bilayers is determined by lipid species. J Am Chem Soc 131:16358-16359
22. Almeida PF (2009) Thermodynamics of lipid interactions in complex bilayers. Biochim Biophys Acta 1788: 72-85
23. Pasenkiewicz-Gierula M, Rog T, Kitamura K, Kusumi A (2000) Cholesterol effects on the phosphatidylcholine bilayer polar region: A molecular simulation study. Biophys J 78:1376-1389
24. Brown DA (2006) Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology( Bethesda) 21:430-439
25. Lingwood D, Simons K (2010) Lipid rafts as a membrane-organizing principle. Science 327:46-50
26. Elson EL, Fried E, Dolbow JE, Genin GM (2010) Phase separation in biological membranes: Integration of theory and experiment. Annu Rev Biophys 39:207-226
27. Brown DA, London E (1998) Structure and origin of ordered lipid domains in biological membranes. J Membr Biol 164:103-114
28. Allende D, Vidal A, McIntosh TJ (2004) Jumping to rafts: Gatekeeper role of bilayer elasticity. Trends Biochem Sci 29:325-330
29. Gandhavadi M, Allende D, Vidal A, Simon SA, McIntosh TJ (2002) Structure, composition, and peptide binding properties of detergent soluble bilayers and detergent resistant rafts. Biophys J 82:1469-1482
30. Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, Gratton E (2001) Lipid rafts reconstituted in model membranes. Biophys J 80:1417-1428
31. Baumgart T, Hess ST, Webb WW (2003) Imaging coexisting fluid domains in biomembrane models coupling curvature and line tension. Nature 425:821-824
32. Veatch SL, Keller SL (2003) Separation of liquid phases in giant vesicles of ternary mixtures of phospholipids and cholesterol. Biophys J 85:3074-3083
33. Kiessling V, Wan C, Tamm LK (2009) Domain coupling in asymmetric lipid bilayers. Biochim Biophys Acta 1788:64-71
34. Munro S (2003) Lipid rafts: Elusive or illusive? Cell 115:377-388
35. Hancock JF (2006) Lipid rafts: Contentious only from simplistic standpoints. Nat Rev Mol Cell Biol 7:456-462
36. Kenworthy AK (2008) Have we become overly reliant on lipid rafts? Talking point on the involvement of lipid rafts in T-cell activation. EMBO Rep 9:531-535
37. Simons K, Gerl MJ (2010) Revitalizing membrane rafts: New tools and insights. Nat Rev Mol Cell Biol 11: 688-699
38. Kraft ML (2013) Plasma membrane organization and function: Moving past lipid rafts. Mol Biol Cell 24: 2765-2768
39. LaRocca TJ, Pathak P, Chiantia S, Toledo A, Silvius JR, Benach JL, London E (2013) Proving lipid rafts exist: Membrane domains in the prokaryote Borrelia burgdorferi have the same properties as eukaryotic lipid rafts. PLoS Pathogens 9:e1003353
40. Kusumi A, Fujiwara TK, Chadda R, Xie M, Tsunoyama TA, Kalay Z, Kasai RS, Suzuki KG (2012) Dynamic organizing principles of the plasma membrane that regulate signal transduction: Commemorating the fortieth anniversary of Singer and Nicolson?s fluid-mosaic model. Annu Rev Cell Dev Biol 28:215-250
41. Toulmay A, Prinz WA (2013) Direct imaging reveals stable, micrometer-scale lipid domains that segregate proteins in live cells. J Cell Biol 202:35-44
42. Sezgin E, Kaiser HJ, Baumgart T, Schwille P, Simons K, Levental I (2012) Elucidating membrane structure and protein behavior using giant plasma membrane vesicles. Nat Protoc 7:1042-1051
43. Baumgart T, Hammond AT, Sengupta P, Hess ST, Holowka DA, Baird BA, Webb WW (2007) Large-scale fluid/fluid phase separation of proteins and lipids in giant plasma membrane vesicles. Proc Natl Acad Sci USA 104:3165-3170
44. Veatch SL, Cicuta P, Sengupta P, Honerkamp-Smith A, Holowka D, Baird B (2008) Critical fluctuations in plasma membrane vesicles. ACS Chem Biol 3:287-293
45. Honerkamp-Smith AR, Veatch SL, Keller SL (2009) An introduction to critical points for biophysicists; observations of compositional heterogeneity in lipid membranes. Biochim Biophys Acta 1788:53-63
46. Veatch SL, Keller SL (2005) Seeing spots: Complex phase behavior in simple membranes. Biochim Biophys Acta 1746:172-185
47. Veatch SL, Keller SL (2005) Miscibility phase diagrams of giant vesicles containing sphingomyelin. Phys Rev Lett 94:148101
48. Foster LJ (2009) Moving closer to the lipid raft proteome using quantitative proteomics. Methods Mol Biol 528:189-199
49. Levental I, Lingwood D, Grzybek M, Coskun U, Simons K (2010) Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc Natl Acad Sci USA 107:22050-22054
50. Levental I, Grzybek M, Simons K (2010) Greasing their way: Lipid modifications determine protein association with membrane rafts. Biochemistry 49:6305-6316
51. Lin Q, London E (2013) Altering hydrophobic sequence lengths shows that hydrophobic mismatch controls affinity for ordered lipid domains (rafts) in the multitransmembrane strand protein perfringolysin O. J Biol Chem 288:1340-1352
52. Kahya N (2006) Targeting membrane proteins to liquid-ordered phases: Molecular self-organization explored by fluorescence correlation spectroscopy. Chem Phys Lipids 141:158-168
53. Silvius JR (2005) Partitioning of membrane molecules between raft and non-raft domains: Insights from model-membrane studies. Biochim Biophys Acta 1746: 193-202
54. McIntosh TJ, Simon SA (2006) Roles of bilayer material properties in function and distribution of membrane proteins. Annu Rev Biophys Biomol Struct 35: 177-198
55. Kahya N (2010) Protein-protein and protein-lipid interactions in domain-assembly: Lessons from giant unilamellar vesicles. Biochim Biophys Acta 1798:1392-1398
56. Sezgin E, Levental I, Grzybek M, Schwarzmann G, Mueller V, Honigmann A, Belov VN, Eggeling C, Coskun U, Simons K, Schwille P (2012) Partitioning, diffusion, and ligand binding of raft lipid analogs in model and cellular plasma membranes. Biochim Biophys Acta 1818:1777-1784
57. Sengupta P, Hammond A, Holowka D, Baird B (2008) Structural determinants for partitioning of lipids and proteins between coexisting fluid phases in giant plasma membrane vesicles. Biochim Biophys Acta 1778:20-32
58. Tong J, Briggs MM, Mlaver D, Vidal A, McIntosh TJ( 2009) Sorting of lens aquaporins and connexins into raft and nonraft bilayers: Role of protein homo-oligomerization. Biophys J 97:2493-2502
59. Lee AG (2004) How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta 1666: 62-87
60. Jafurulla M, Chattopadhyay A (2013) Membrane lipids in the function of serotonin and adrenergic receptors. Curr Med Chem 20:47-55
61. Barrantes FJ, Bermudez V, Borroni MV, Antollini SS, Pediconi MF, Baier JC, Bonini I, Gallegos C, Roccamo AM, Valles AS, Ayala V, Kamerbeek C (2010) Boundary lipids in the nicotinic acetylcholine receptor microenvironment. J Mol Neurosci 40:87-90
62. Phillips R, Ursell T, Wiggins P, Sens P (2009) Emerging roles for lipids in shaping membrane-protein function. Nature 459:379-385
63. Lee AG (2011) Biological membranes: The importance of molecular detail. Trends Biochem Sci 36:493-500
64. Marsh D (2008) Protein modulation of lipids, and viceversa, in membranes. Biochim Biophys Acta 1778: 1545-1575
65. Soubias O, Gawrisch K (2012) The role of the lipid matrix for structure and function of the GPCR rhodopsin. Biochim Biophys Acta 1818:234-240
66. Jastrzebska B, Debinski A, Filipek S, Palczewski K( 2011) Role of membrane integrity on G proteincoupled receptors: Rhodopsin stability and function. Progr Lipid Res 50:267-277
67. Hong H, Blois TM, Cao Z, Bowie JU (2010) Method to measure strong protein-protein interactions in lipid bilayers using a steric trap. Proc Natl Acad Sci USA 107:19802-19807
68. Hong H, Chang YC, Bowie JU (2013) Measuring transmembrane helix interaction strengths in lipid bilayers using steric trapping. Methods Mol Biol 1063:37-56
69. Marius P, Zagnoni M, Sandison ME, East JM, Morgan H, Lee AG (2008) Binding of anionic lipids to at least three nonannular sites on the potassium channel KcsA is required for channel opening. Biophys J 94:1689-1698
70. Wood WG, Igbavboa U, Muller WE, Eckert GP (2011) Cholesterol asymmetry in synaptic plasma membranes. J Neurochem 116:684-689
71. van Meer G (2011) Dynamic transbilayer lipid asymmetry. Cold Spring Harbor Perspect Biol 3:a004671
72. De Fabiani E, Mitro N, Gilardi F, Crestani M (2010) Sterol-protein interactions in cholesterol and bile acid synthesis. Subcell Biochem 51:109-135
73. Tarling EJ, de Aguiar Vallim TQ, Edwards PA (2013) Role of ABC transporters in lipid transport and human disease. Trends Endocrinol Metab 24:342-350
74. Rone MB, Fan J, Papadopoulos V (2009) Cholesterol transport in steroid biosynthesis: Role of proteinprotein interactions and implications in disease states. Biochim Biophys Acta 1791:646-658
75. McLean KJ, Hans M, Munro AW (2012) Cholesterol, an essential molecule: Diverse roles involving cytochrome P450 enzymes. Biochem Soc Trans 40:587-593
76. Goedeke L, Fernandez-Hernando C (2012) Regulation of cholesterol homeostasis. Cell Mol Life Sci 69:915-930
77. Gimpl G, Reitz J, Brauer S, Trossen C (2008) Oxytocin receptors: Ligand binding, signalling and cholesterol dependence. Progr Brain Res 170:193-204
78. Steck TL, Lange Y (2010) Cell cholesterol homeostasis: Mediation by active cholesterol. Trends Cell Biol 20: 680-687
79. Brown MS, Goldstein JL (2009) Cholesterol feedback: From Schoenheimer?s bottle to Scap?s MELADL. J Lipid Res 50(Suppl):S15-S27
80. Schroeder C (2010) Cholesterol-binding viral proteins in virus entry and morphogenesis. Subcell Biochem 51: 77-108
81. Lippincott-Schwartz J, Phair RD (2010) Lipids and cholesterol as regulators of traffic in the endomembrane system. Annu Rev Biophys 39:559-578
82. Beel AJ, Sakakura M, Barrett PJ, Sanders CR (2010) Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer?s disease relationships? Biochim Biophys Acta 1801:975-982
83. Hotze EM, Tweten RK (2012) Membrane assembly of the cholesterol-dependent cytolysin pore complex. Biochim Biophys Acta 1818:1028-1038
84. Skocaj M, Bakrac B, Krizaj I, Macek P, Anderluh G, Sepcic K (2013) The sensing of membrane microdomains based on pore-forming toxins. Curr Med Chem 20:491-501
85. Gilbert RJ (2010) Cholesterol-dependent cytolysins. Adv Exp Med Biol 677:56-66
86. Hulce JJ, Cognetta AB, Niphakis MJ, Tully SE, Cravatt BF (2013) Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nat Methods 10:259-264
87. Lascombe MB, Ponchet M, Venard P, Milat ML, Blein JP, Prange T (2002) The 1.45 A resolution structure of the cryptogein-cholesterol complex: A close-up view of a sterol carrier protein (SCP) active site. Acta Crystallogr D Biol Crystallogr 58:1442-1447
88. Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, Delhon I, Fournier B (2002) X-ray structure of the hRORalpha LBD at 1.63 A: Structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 10:1697-1707
89. Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137: 1213-1224
90. Im YJ, Raychaudhuri S, Prinz WA, Hurley JH (2005) Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature 437:154-158
91. Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW (2011) Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci USA 108:10139-10143
92. Ogawa H, Shinoda T, Cornelius F, Toyoshima C (2009) Crystal structure of the sodium-potassium pump( Na1,K1-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA 106:13742-13747
93. Shinoda T, Ogawa H, Cornelius F, Toyoshima C (2009) Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 459:446-450
94. Laursen M, Yatime L, Nissen P, Fedosova NU (2013) Crystal structure of the high-affinity Na1,K1-ATPaseouabain complex with Mg21 bound in the cation binding site. Proc Natl Acad Sci USA 110:10958-10963
95. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL, Petersen J, Andersen JP, Vilsen B, Nissen P (2007) Crystal structure of the sodium-potassium pump. Nature 450:1043-1049
96. Wacker D, Fenalti G, Brown MA, Katritch V, Abagyan R, Cherezov V, Stevens RC (2010) Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc 132:11443-11445
97. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318:1258-1265
98. Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, Rasmussen SG, Choi HJ, Devree BT, Sunahara RK, Chae PS, Gellman SH, Dror RO, Shaw DE, Weis WI, Caffrey M, Gmeiner P, Kobilka BK( 2011) Structure and function of an irreversible agonist- beta(2) adrenoceptor complex. Nature 469:236-240
99. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, Velasquez J, Kuhn P, Stevens RC (2008) A specific cholesterol binding site is established by the 2.8 A structure of the human beta2- adrenergic receptor. Structure 16:897-905
100. Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, Liu W, Xu HE, Cherezov V, Roth BL, Stevens RC (2013) Structural features for functional selectivity at serotonin receptors. Science 340:615-619
101. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S (2012) Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 485:321-326
102. Liu W, Chun E, Thompson AA, Chubukov P, Xu F, Katritch V, Han GW, Roth CB, Heitman LH,Cherezov V, Stevens RC (2012) Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337:232-236
103. Wada T, Shimono K, Kikukawa T, Hato M, Shinya N, Kim SY, Kimura-Someya T, Shirouzu M, Tamogami J, Miyauchi S, Jung KH, Kamo N, Yokoyama S (2011) Crystal structure of the eukaryotic light-driven proton- pumping rhodopsin, Acetabularia rhodopsin II, from marine alga. J Mol Biol 411:986-998
104. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Yao XJ, Weis WI, Stevens RC, Kobilka BK (2007) GPCR engineering yields high-resolution structural insights into beta2- adrenergic receptor function. Science 318:1266-1273
105. Holt A, de Almeida RF, Nyholm TK, Loura LM, Daily AE, Staffhorst RW, Rijkers DT, Koeppe RE, IInd, Prieto M, Killian JA (2008) Is there a preferential interaction between cholesterol and tryptophan residues in membrane proteins? Biochemistry 47:2638-2649
106. Fantini J, Barrantes FJ (2013) How cholesterol interacts with membrane proteins: An exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol 4:31
107. Epand RM, Thomas A, Brasseur R, Epand RF (2010) Cholesterol interaction with proteins that partition into membrane domains: An overview. Subcell Biochem 51:253-278
108. Li H, Papadopoulos V (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/ interaction amino acid sequence and consensus pattern. Endocrinology 139:4991-4997
109. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V( 2001) Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 98:1267-1272
110. Baier CJ, Fantini J, Barrantes FJ (2011) Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor. Sci Rep 1:69
111. Visiers I, Ballesteros JA, Weinstein H (2002) Threedimensional representations of G protein-coupled receptor structures and mechanisms. Methods Enzymol. 343:329-371
112. Palmer M (2004) Cholesterol and the activity of bacterial toxins. FEMS Microbiol Lett 238:281-289
113. Kuwabara PE, Labouesse M (2002) The sterol-sensing domain: Multiple families, a unique role? Trends Genet 18:193-201
114. Motamed M, Zhang Y, Wang ML, Seemann J, Kwon HJ, Goldstein JL, Brown MS (2011) Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis. J Biol Chem 286:18002-18012
115. Song Y, Hustedt EJ, Brandon S, Sanders CR (2013) Competition between homodimerization and cholesterol binding to the c99 domain of the amyloid precursor protein. Biochemistry 52:5051-5064
116. Barrett PJ, Song Y, Van Horn WD, Hustedt EJ, Schafer JM, Hadziselimovic A, Beel AJ, Sanders CR( 2012) The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol. Science 336:1168-1171
117. O?Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer?s disease. Annu Rev Neurosci 34:185-204
118. Selkoe DJ (2011) Alzheimer?s disease. Cold Spring Harbor Perspect Biol 3:a004457
119. Beel AJ, Mobley CK, Kim HJ, Tian F, Hadziselimovic A, Jap B, Prestegard JH, Sanders CR (2008) Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): Does APP function as a cholesterol sensor? Biochemistry 47:9428-9446
120. Ram P, Prestegard JH (1988) Magnetic field induced ordering of bile salt/phospholipid micelles: New media for NMR structural investigations. Biochim Biophys Acta 940:289-294
121. Sanders CR, 2nd, Prestegard JH (1990) Magnetically orientable phospholipid bilayers containing small amounts of a bile salt analogue, CHAPSO. Biophys J 58:447-460
122. Sanders CR, Hare BJ, Howard KP, Prestegard JH( 1994) Magnetically- oriented phospholipid micelles as a tool for the study of membrane-associated molecules. Progr Nucl Magn Reson Spectrosc 26:421-444
123. Sanders CR, IInd, Schwonek JP (1992) Characterization of magnetically orientable bilayers in mixtures of dihexanoylphosphatidylcholine and dimyristoylphosphatidylcholine by solid-state NMR. Biochemistry 31: 8898-8905
124. Sanders CR, 2nd, Landis GC (1995) Reconstitution of membrane proteins into lipid-rich bilayered mixed micelles for NMR studies. Biochemistry 34:4030-4040
125. Minto RE, Adhikari PR, Lorigan GA (2004) A 2H solid-state NMR spectroscopic investigation of biomimetic bicelles containing cholesterol and polyunsaturated phosphatidylcholine. Chem Phys Lipids 132:55-64
126. Lemmon MA, Flanagan JM, Hunt JF, Adair BD, Bormann BJ, Dempsey CE, Engelman DM (1992) Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. J Biol Chem 267:7683-7689
127. MacKenzie KR, Prestegard JH, Engelman DM (1997) A transmembrane helix dimer: Structure and implications. Science 276:131-133
128. Kim S, Jeon TJ, Oberai A, Yang D, Schmidt JJ, Bowie JU (2005) Transmembrane glycine zippers: Physiological and pathological roles in membrane proteins. Proc Natl Acad Sci USA 102:14278-14283
129. Doura AK, Kobus FJ, Dubrovsky L, Hibbard E, Fleming KG (2004) Sequence context modulates the stability of a GxxxG-mediated transmembrane helixhelix dimer. J Mol Biol 341:991-998
130. Wang H, Barreyro L, Provasi D, Djemil I, Torres- Arancivia C, Filizola M, Ubarretxena-Belandia I( 2011) Molecular determinants and thermodynamics of the amyloid precursor protein transmembrane domain implicated in Alzheimer?s disease. J Mol Biol 408:879-895
131. Lau TL, Dua V, Ulmer TS (2008) Structure of the integrin alphaIIb transmembrane segment. J Biol Chem 283:16162-16168
132. Yanagisawa K (2005) Cholesterol and amyloid beta fibrillogenesis. Subcell Biochem 38:179-202
133. Leduc V, Jasmin-Belanger S, Poirier J (2010) APOE and cholesterol homeostasis in Alzheimer?s disease. Trends Mol Med 16:469-477
134. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ( 2012) Vascular risk factors and Alzheimer?s disease: Are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther 4:1
135. Fonseca AC, Resende R, Oliveira CR, Pereira CM( 2010) Cholesterol and statins in Alzheimer?s disease: Current controversies. Exp Neurol 223:282-293
136. Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer?s disease. J Neurochem 111:1275-1308
137. Rushworth JV, Hooper NM (2010) Lipid rafts: Linking Alzheimer?s amyloid-beta production, aggregation, and toxicity at neuronal membranes. Int J Alzheimers Dis 2011:603052
138. Di Paolo G, Kim TW (2011) Linking lipids to Alzheimer?s disease: Cholesterol and beyond. Nat Rev Neurosci 12:284-296
139. Hicks DA, Nalivaeva NN, Turner AJ (2012) Lipid rafts and Alzheimer?s disease: Protein-lipid interactions and perturbation of signaling. Front Physiol 3: 189
140. Korade Z, Kenworthy AK (2008) Lipid rafts, cholesterol, and the brain. Neuropharmacology 55:1265-1273
141. Bjorkhem I, Meaney S (2004) Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24:806-815
142. Dietschy JM, Turley SD (2004) Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45:1375-1397
143. Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2:a006270
144. Kojro E, Fahrenholz F (2005) The non-amyloidogenic pathway: Structure and function of alpha-secretases. Subcell Biochem 38:105-127
145. Nalivaeva NN, Turner AJ (2013) The amyloid precursor protein: A biochemical enigma in brain development, function and disease. FEBS Lett 587:2046-2054
146. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-6464
147. Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, Younkin LH, Younkin SG, Golde TE (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 9:11-23
148. Bodovitz S, Klein WL (1996) Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 271:4436-4440
149. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F( 2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci USA 98:5815-5820
150. Marenchino M, Williamson PT, Murri S, Zandomeneghi G, Wunderli-Allenspach H, Meier BH, Kramer SD (2008) Dynamics and Cleavability at the alpha-cleavage site of APP(684-726) in different lipid environments. Biophys J 95:1460-1473
151. Osenkowski P, Ye W, Wang R, Wolfe MS, Selkoe DJ( 2008) Direct and potent regulation of gammasecretase by its lipid microenvironment. J Biol Chem 283:22529-22540
152. Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, Herz J, Muglia L, Bu G (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56:66-78
153. Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, De Strooper B, Muller U, Shen J, Hartmann T (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol 7:1118-1123
154. Grimm MO, Grimm HS, Hartmann T (2007) Amyloid beta as a regulator of lipid homeostasis. Trends Mol Med 13:337-344
155. Grimm MO, Rothhaar TL, Hartmann T (2012) The role of APP proteolytic processing in lipid metabolism. Exp Brain Res 217:365-375
156. Decottignies A, Sanchez-Perez I, Nurse P (2003) Schizosaccharomyces pombe essential genes: A pilot study. Genome Res 13:399-406
157. Mahadevan R, Lovley DR (2008) The degree of redundancy in metabolic genes is linked to mode of metabolism. Biophys J 94:1216-1220
158. Zheng H, Koo EH (2011) Biology and pathophysiology of the amyloid precursor protein.Mol Neurodegener 6:27
159. Pierrot N, Tyteca D, D?Auria L, Dewachter I, Gailly P, Hendrickx A, Tasiaux B, Haylani LE, Muls N, N?Kuli F, Laquerriere A, Demoulin JB, Campion D, Brion JP, Courtoy PJ, Kienlen-Campard P, Octave JN (2013) Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol Med 5: 608-625
160. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols. Cell 124:35-46
161. Hughes TM, Rosano C, Evans RW, Kuller LH (2013) Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis 33:891-911
162. Mohamed A, Saavedra L, Di Pardo A, Sipione S, Posse de Chaves E (2012) beta-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage. J Neurosci 32:6490-6500